JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Clinical Pathology 2007;60:947-948; doi:10.1136/jcp.2006.037473
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vázquez-Mellado, J
Right arrow Articles by Cuevas-Covarrubias, S A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vázquez-Mellado, J
Right arrow Articles by Cuevas-Covarrubias, S A
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Gout
*Joint Disorders

SHORT REPORTS

Homozygous frameshift mutation in the SLC22A12 gene in a patient with primary gout and high levels of serum uric acid

J Vázquez-Mellado1, V Alvarado-Romano1, R Burgos-Vargas1, A L Jiménez-Vaca2, G Pozo-Molina3, S A Cuevas-Covarrubias4

1 Rheumatology Service, Hospital General de México, Facultad de Medicina, Universidad Nacional Autónoma de México, México DF, Mexico
2 Hematology Service, Hospital General de México, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico DF, Mexico
3 Molecular Biology and Genetics Department, CINVESTAV, IPN, Mexico DF, Mexico.
4 Genetic Service, Hospital General de México, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico DF, Mexico

Correspondence to:
Dr S Cuevas-Covarrubias
Servicio de Genética, Hospital General de México, Fac. Medicina, UNAM, Dr Balmis 148 Col Doctores CP 06726, Mexico DF, Mexico; sergioa@servidor.unam.mx 20 July 2006

The first 150 words of the full text of this article appear below.

Idiopathic renal hypouricaemia (IRH), an autosomal recessive disorder, is an uncommon disease that presents with an increase in uric acid excretion. Most patients with IRH have homozygous deleterious mutations in the SLC22A12 gene that encodes for URAT1 protein. Gout is a multifactorial metabolic disease caused by the deposition of urate crystals. This study describes a patient with high levels of uric acid, primary gout and a novel SLC22A12 gene mutation, which is associated to IRH. The patient showed a 1 bp homozygous insertion (680insG) that resulted in substitution of threonine instead of alanine and in a premature stop codon. This finding provides information about the influence of environmental and/or epigenetic factors in Mendelian inheritance.

Idiopathic renal hypouricaemia (IRH) is an autosomal recessive disorder characterised by increased uric acid excretion.1 The main biochemical defect is abnormal uric acid transport at the proximal tubule. URAT protein seems to be the major mechanism . . . [Full text of this article]




This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
S. A. Eraly, V. Vallon, T. Rieg, J. A. Gangoiti, W. R. Wikoff, G. Siuzdak, B. A. Barshop, and S. K. Nigam
Multiple organic anion transporters contribute to net renal excretion of uric acid
Physiol Genomics, April 1, 2008; 33(2): 180 - 192.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.